Journal:Acta Cryst D:S2059798322000948
From Proteopedia
(Difference between revisions)

| Line 10: | Line 10: | ||
In this paper, we describe a new inactive structure of the main protease of SARS-CoV-2 ([[7nij]]). Movements in the substrate-binding region and near the catalytic site result in a significant reshaping of the reaction center. <scene name='90/902772/Cv1/1'>Comparison between different oxyanion loop conformations</scene> of M<sup>pro</sup>: “active” in SARS-CoV-2 M<sup>pro</sup> [[6y2e]] in pink; “collapsed-inactive” in SARS-CoV M<sup>pro</sup> [[1uj1]] chain B in magenta; “new-inactive” in SARS-CoV-2 M<sup>pro</sup> [[7nij]] in green. Consequently, the conformation adopted by residues 139-144 of the oxyanion loop is catalytically-incompetent. <scene name='90/902772/Cv1/5'>New conformation of the oxyanion loop is stabilized by several hydrogen bonds</scene> (white dashed lines). The side-chain of catalytic Cys145 has a double conformation. Phe140, Leu141 and Asn142 play a major role in the shift between the new inactive and active conformations. <scene name='90/902772/Cv1/8'>Comparison between new-inactive and active oxyanion loop</scene>. The new-inactive oxyanion loop ([[7nij]]) is in green and the active loop ([[6y2e]]) is in pink. There are large movements (white dashed lines) for the side-chains of Asn142 and Phe140. In the new-inactive conformation, Asn142 moves from an exposed position, ASA 153.74 Å<sup>2</sup>, to a buried one, ASA 49.00 Å<sup>2</sup> and Phe140 moves from a buried position, ASA 14.79 Å<sup>2</sup>, to an exposed one, ASA 143.29 Å<sup>2</sup>. Gly143-NH (G-NH) of the oxyanion hole, involved in the stabilization of the tetrahedral intermediate, moves 8.8 Å away. | In this paper, we describe a new inactive structure of the main protease of SARS-CoV-2 ([[7nij]]). Movements in the substrate-binding region and near the catalytic site result in a significant reshaping of the reaction center. <scene name='90/902772/Cv1/1'>Comparison between different oxyanion loop conformations</scene> of M<sup>pro</sup>: “active” in SARS-CoV-2 M<sup>pro</sup> [[6y2e]] in pink; “collapsed-inactive” in SARS-CoV M<sup>pro</sup> [[1uj1]] chain B in magenta; “new-inactive” in SARS-CoV-2 M<sup>pro</sup> [[7nij]] in green. Consequently, the conformation adopted by residues 139-144 of the oxyanion loop is catalytically-incompetent. <scene name='90/902772/Cv1/5'>New conformation of the oxyanion loop is stabilized by several hydrogen bonds</scene> (white dashed lines). The side-chain of catalytic Cys145 has a double conformation. Phe140, Leu141 and Asn142 play a major role in the shift between the new inactive and active conformations. <scene name='90/902772/Cv1/8'>Comparison between new-inactive and active oxyanion loop</scene>. The new-inactive oxyanion loop ([[7nij]]) is in green and the active loop ([[6y2e]]) is in pink. There are large movements (white dashed lines) for the side-chains of Asn142 and Phe140. In the new-inactive conformation, Asn142 moves from an exposed position, ASA 153.74 Å<sup>2</sup>, to a buried one, ASA 49.00 Å<sup>2</sup> and Phe140 moves from a buried position, ASA 14.79 Å<sup>2</sup>, to an exposed one, ASA 143.29 Å<sup>2</sup>. Gly143-NH (G-NH) of the oxyanion hole, involved in the stabilization of the tetrahedral intermediate, moves 8.8 Å away. | ||
| - | The movements of the oxyanion loop and of the N- and C-termini result in the weakening of the dimeric architecture, as evidenced by the decreases in the interaction surface area and in the number of inter-protomer interactions. This novel conformation is relevant both for the comprehension of the mechanism of action of M<sup>pro</sup> within the catalytic cycle and for the success of the structure-based drug design of anti-viral drugs. | + | The movements of the oxyanion loop and of the N- and C-termini result in the weakening of the dimeric architecture, as evidenced by the decreases in the interaction surface area and in the number of inter-protomer interactions. This novel conformation is relevant both for the comprehension of the mechanism of action of M<sup>pro</sup> within the catalytic cycle and for the success of the structure-based drug design of anti-viral drugs. |
| - | *<scene name='90/902772/Cv3/2'> | + | Reshaping of the S1 and S2' subsites. Molecular dynamics modeling of the hypothetical interaction of new-inactive M<sup>pro</sup> with substrates is shown. Putative interaction with the 11<sub>mer</sub> pseudo-substrate peptide from structure [[2q6g]]: |
| + | |||
| + | *<scene name='90/902772/Cv3/2'>SARS-CoV Mpro from 2q6g</scene>. | ||
<b>References</b><br> | <b>References</b><br> | ||
Revision as of 17:50, 6 February 2022
| |||||||||||
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
